Roche Holding AG's Fiscal Year is From January To December.
The item "Price-To-Cashflow-Ratio" stands at 12.33 as of 06/30/2025.
As of the end of Roche Holding AG's second quarter, the item "Price To Cashflow Ratio" stands at 12.33. This represents a decrease of -6.04 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -8.28 percent compared to the value the year prior.
The 1 year change in percent is -8.28.
The 3 year change in percent is 51.58.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Price To Cashflow Ratio | 905,699,262,464.00 |
![]() | Johnson & Johnson - Price To Cashflow Ratio | 486,508,953,600.00 |
![]() | AbbVie Inc - Price To Cashflow Ratio | 399,570,305,024.00 |
![]() | AstraZeneca PLC - Price To Cashflow Ratio | 280,205,508,085.11 |
![]() | Novartis AG - Price To Cashflow Ratio | 255,096,620,580.91 |